↓ Skip to main content

Febuxostat for treating chronic gout

Overview of attention for article published in Cochrane database of systematic reviews, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

blogs
1 blog
twitter
12 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
147 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Febuxostat for treating chronic gout
Published in
Cochrane database of systematic reviews, November 2012
DOI 10.1002/14651858.cd008653.pub2
Pubmed ID
Authors

Jean H Tayar, Maria Angeles Lopez-Olivo, Maria E Suarez-Almazor

Abstract

Gout is the most common inflammatory arthritis in men over 40 years and has an increasing prevalence among postmenopausal women. Lowering serum uric acid levels remains one of the primary goals in the treatment of chronic gout. In clinical trials, febuxostat has been shown to be effective in lowering serum uric acid levels to < 6.0 mg/dL.

Twitter Demographics

The data shown below were collected from the profiles of 12 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 147 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 1%
United Kingdom 1 <1%
Italy 1 <1%
Denmark 1 <1%
Unknown 142 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 29 20%
Student > Bachelor 28 19%
Researcher 17 12%
Student > Ph. D. Student 14 10%
Student > Postgraduate 10 7%
Other 13 9%
Unknown 36 24%
Readers by discipline Count As %
Medicine and Dentistry 57 39%
Nursing and Health Professions 10 7%
Pharmacology, Toxicology and Pharmaceutical Science 8 5%
Social Sciences 7 5%
Psychology 5 3%
Other 16 11%
Unknown 44 30%

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 February 2020.
All research outputs
#1,752,042
of 21,339,655 outputs
Outputs from Cochrane database of systematic reviews
#4,012
of 12,082 outputs
Outputs of similar age
#20,441
of 290,369 outputs
Outputs of similar age from Cochrane database of systematic reviews
#183
of 477 outputs
Altmetric has tracked 21,339,655 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,082 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.0. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 290,369 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 477 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.